Clearmind Medicine (CMND) Cash & Current Investments (2021 - 2026)

Clearmind Medicine's Cash & Current Investments history runs 6 years deep, the most recent figure standing at $13.6 million for Q2 2026.

• In Q2 2026, Cash & Current Investments rose 192.32% year-over-year to $13.6 million; the TTM figure through Apr 2026 stood at $13.6 million (up 192.32% YoY), while the FY2025 annual figure was $5.6 million, down 18.62% from the prior year.
• Cash & Current Investments for Q2 2026 stood at $13.6 million, up from $10.3 million in the prior quarter.
• The five-year high for Cash & Current Investments was $13.6 million in Q2 2026, with the low at $147392.8 in Q4 2022.
• The 5-year median for Cash & Current Investments is $5.6 million (2025), against an average of $6.1 million.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments sank 95.99% in 2022, then jumped 3640.92% in 2023.
• Clearmind Medicine's Cash & Current Investments stood at $147392.8 in 2022, then surged by 3640.92% to $5.5 million in 2023, then increased by 24.47% to $6.9 million in 2024, then retreated by 18.62% to $5.6 million in 2025, then surged by 143.37% to $13.6 million in 2026.
• Business Quant data shows CMND's Cash & Current Investments at $13.6 million in Q2 2026, $10.3 million in Q1 2026, and $5.6 million in Q4 2025.